Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Videos

Waqqas Afif
Video
Waqqas Afif, MD, on Ustekinumab for Ulcerative Colitis
01/16/2023
Dr Afif, from McGill University, reviews the final results of a 4-year study on the safety and efficacy of ustekinumab among patients with ulcerative colitis.
Dr Afif, from McGill University, reviews the final results of a 4-year study on the safety and efficacy of ustekinumab among patients with ulcerative colitis.
Dr Afif, from McGill University,...
01/16/2023
Advances in Inflammatory Bowel Disease Network

Advertisement

Infusion
Conference Coverage
Miguel Regueiro, MD, and Corey Siegel, MD: If, When, and How to Stop IBD Therapy
12/31/2022
Drs Regueiro and Siegel review their debate from the Advances in Inflammatory Bowel DIseases 2022 annual meeting about if, when, and how to stop or de-escalate therapy for IBD.
Drs Regueiro and Siegel review their debate from the Advances in Inflammatory Bowel DIseases 2022 annual meeting about if, when, and how to stop or de-escalate therapy for IBD.
Drs Regueiro and Siegel review...
12/31/2022
Advances in Inflammatory Bowel Disease Network
Bruce Sands
Video
Bruce Sands, MD, on the QUASAR Study of Guselkumab in Ulcerative Colitis
12/27/2022
Dr Sands, from the Icahn School of Medicine at Mt Sinai in New York, discusses the results from the QUASAR study of guselkumab in ulcerative colitis, in which nonresponding patients received subcutaneous drug over an additional 12 weeks to...
Dr Sands, from the Icahn School of Medicine at Mt Sinai in New York, discusses the results from the QUASAR study of guselkumab in ulcerative colitis, in which nonresponding patients received subcutaneous drug over an additional 12 weeks to...
Dr Sands, from the Icahn School...
12/27/2022
Advances in Inflammatory Bowel Disease Network
Gil Melmed
Conference Coverage
Gil Y Melmed, MD, on Neurologic Complication in IBD
12/07/2022
Dr Melmed, from Cedars-Sinai in Los Angeles, discusses neurological complications that may arise among patients being treated for inflammatory bowel disease--and what clinicians should watch for to prevent or mitigate them.
Dr Melmed, from Cedars-Sinai in Los Angeles, discusses neurological complications that may arise among patients being treated for inflammatory bowel disease--and what clinicians should watch for to prevent or mitigate them.
Dr Melmed, from Cedars-Sinai in...
12/07/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Miguel Regueiro MD
Conference Coverage
Miguel Regueiro, MD, on a Practical Approach to Positioning IBD Therapies
12/06/2022
Dr Regueiro, from Cleveland Clinic, reviews the armamentarium of therapies available today for inflammatory bowel diseases and how best to position them to optimize outcomes among patients.
Dr Regueiro, from Cleveland Clinic, reviews the armamentarium of therapies available today for inflammatory bowel diseases and how best to position them to optimize outcomes among patients.
Dr Regueiro, from Cleveland...
12/06/2022
Advances in Inflammatory Bowel Disease Network
David Rubin
Conference Coverage
David Rubin, MD, on Managing Dysplasia in IBD
12/06/2022
Dr Rubin, from the University of Chicago, explains key points from his presentation at AIBD 2022 on risks of colon cancer among patients with inflammatory bowel disease and how to best monitor for dysplasia and mitigate risks.
Dr Rubin, from the University of Chicago, explains key points from his presentation at AIBD 2022 on risks of colon cancer among patients with inflammatory bowel disease and how to best monitor for dysplasia and mitigate risks.
Dr Rubin, from the University of...
12/06/2022
Advances in Inflammatory Bowel Disease Network
Alan Moss, MD
Conference Coverage
Alan Moss, MD, on Defining Disease Severity in IBD
12/06/2022
Dr Moss, from Boston University School of Medicine, discusses his presentation on defining severity of inflammatory bowel disease, including differences in patient and physician perceptions.
Dr Moss, from Boston University School of Medicine, discusses his presentation on defining severity of inflammatory bowel disease, including differences in patient and physician perceptions.
Dr Moss, from Boston University...
12/06/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Stephen Hanauer
Conference Coverage
Stephen Hanauer, MD, on Human Models of IBD
12/05/2022
Dr Hanauer, from Northwestern University Feinberg School of Medicine in Chicago, reviews his keynote address at the Advances in Inflammatory Bowel Diseases meeting on how variations in the presentation of IBD provide human models for the...
Dr Hanauer, from Northwestern University Feinberg School of Medicine in Chicago, reviews his keynote address at the Advances in Inflammatory Bowel Diseases meeting on how variations in the presentation of IBD provide human models for the...
Dr Hanauer, from Northwestern...
12/05/2022
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky MD
Conference Coverage
Marla Dubinsky, MD, on Brave New World: Positioning Biologics for Pediatric Patients With IBD
12/05/2022
Dr Dubinsky, from the Icahn School of Medicine at Mount Sinai in New York City, reviews her keynote presentation on the use of newer biologics with pediatric patients with inflammatory bowel diseases.
Dr Dubinsky, from the Icahn School of Medicine at Mount Sinai in New York City, reviews her keynote presentation on the use of newer biologics with pediatric patients with inflammatory bowel diseases.
Dr Dubinsky, from the Icahn...
12/05/2022
Advances in Inflammatory Bowel Disease Network
Marla Dubinsky MD
Video
The Sherman Prize 2022: Marla Dubinsky, MD
12/01/2022
Dr Dubinsky, from the Icahn School of Medicine at Mt Sinai in New York City, is one of the recipients of the Sherman Prize for 2022, which honors clinicians, surgeons, researchers, and/or academics with extraordinary track records of...
Dr Dubinsky, from the Icahn School of Medicine at Mt Sinai in New York City, is one of the recipients of the Sherman Prize for 2022, which honors clinicians, surgeons, researchers, and/or academics with extraordinary track records of...
Dr Dubinsky, from the Icahn...
12/01/2022
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Latest News

News
Lupus and IBD Share Microbiome Features
10/18/2024
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct microbial signatures with significant overlaps between systemic lupus erythematosus and inflammatory bowel disease.
Researchers identified distinct...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Standard Dosing of Infliximab Effective for Steroid-Refractory ASUC
10/18/2024
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and effective for inducing remission in acute severe ulcerative colitis, higher doses and varied induction strategies showed no significant change in response.
While infliximab proved safe and...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
The Risks of Placebo in IBD Drug Trials
10/18/2024
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend alternative trial designs to reduce potential harms to placebo-receiving patients with inflammatory bowel disease.
Investigators recommend...
10/18/2024
Advances in Inflammatory Bowel Disease Network
News
Endoscopic Healing Index Shows Limited Utility for Identifying CD Remission
10/08/2024
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of Chicago recommend using the EHI with another modality to accurately identify inflammation among patients with Crohn’s disease.
Researchers at the University of...
10/08/2024
Advances in Inflammatory Bowel Disease Network
News
Scores Predict Corticosteroid Failure Risk in Patients With ASUC
10/03/2024
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that include several clinical, laboratory, and endoscopic variables may help improve outcomes in patients with acute severe ulcerative colitis.
Risk of rescue scores that...
10/03/2024
Advances in Inflammatory Bowel Disease Network
News
Previous Stricturing Increases Risk of Anastomotic Stricture in Postoperative CD
10/01/2024

Jolynn Tumolo

Jolynn Tumolo
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment are the keys to reducing risk of progressive disease.
Early detection and treatment...
10/01/2024
Advances in Inflammatory Bowel Disease Network
News
Ustekinumab Shows Superior Persistence in CD Patients With Prior Biologic Use
09/30/2024
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line agent, ustekinumab had significantly better persistence than other biologics.
When used after a first-line...
09/30/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Shows Efficacy Among Biologic-Exposed Patients With Crohn’s Disease
09/24/2024
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed upadacitinib significantly improved clinical and endoscopic outcomes, even among patients with prior biologic failure.
A recent study revealed...
09/24/2024
Advances in Inflammatory Bowel Disease Network
FDA alert
FDA Alert
FDA Approves Guselkumab for Moderate to Severe Ulcerative Colitis
09/12/2024
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab is the first and only fully-human, dual-acting monoclonal antibody that blocks IL-23 and binds to CD64.
Johnson & Johnson’s guselkumab...
09/12/2024
Advances in Inflammatory Bowel Disease Network
News
Upadacitinib Provides Rapid Response in Crohn's Disease
08/29/2024
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction trials showed improvement in symptoms of Crohn’s disease within a week.
Pooled data from induction...
08/29/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Latest Podcasts

Freddy Caldera
Podcast
Freddy Caldera, DO, on the RSV Vaccine for Patients With IBD
10/11/2024
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...
Dr Caldera, from the University...
10/11/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Updates on the PIANO Study of IBD and Pregnancy
10/07/2024
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 
IBD Drive Time Hosts Millie...
10/07/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: David Hudesman, MD, on Work Productivity in IBD
09/19/2024
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.
Dr David Hudesman of NYU-Langone...
09/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Erin Forster, MD, on Risankizumab for Ulcerative Colitis
09/03/2024
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical University of South Carolina joins IBD Drive Time hosts Dr Millie Long and Dr Raymond Cross to review results of the trials for risankizumab in ulcerative colitis and discuss its positioning in treatment.
Dr Erin Forster of the Medical...
09/03/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Jordan Axelrad, MD, on IBD and Malignancy
08/19/2024
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr Raymond Cross discuss the considerations for IBD treatment among patients with history of or a newly-diagnosed malignancy, including when to switch IBD treatments, the importance of controlling disease, and how...
Dr Jordan Axelrad and host Dr...
08/19/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Dr Jana Al Hashash on Diet and Nutrition in IBD Care
08/05/2024
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo Clinic—Florida offers guidance on how diet can affect IBD and the best approaches to maintaining adequate nutrition, along with hosts Millie Long, MD, and Raymond Cross, MD.
Dr Jana Al Hashash from Mayo...
08/05/2024
Advances in Inflammatory Bowel Disease Network
Shubha Bhat
Podcast
Shubha Bhat, PharmD, on the Role of the Clinical Pharmacist in IBD
07/25/2024
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent systematic review and RAND consensus process to define the role of the clinical pharmacist in caring for patients with inflammatory bowel disease.
Dr Bhat reports on the recent...
07/25/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: The Best of DDW, Part 2
07/18/2024
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast, cohost Dr Millie Long discusses her picks for the "Best of DDW" on inflammatory bowel disease with her cohost, Dr Ray Cross.
In part 2 of this podcast,...
07/18/2024
Advances in Inflammatory Bowel Disease Network
IBD Drive time logo
Podcast
IBD Drive Time: Best of DDW, Part 1
07/09/2024
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this two-part series, Dr Raymond Cross of Mercy Medical Center reviews his top picks for the best abstracts on inflammatory bowel disease presented at this year's Digestive Disease Week with cohost Dr Millie Long of...
In the first episode of this...
07/09/2024
Advances in Inflammatory Bowel Disease Network
Millie Long
Video
Millie Long, MD, on Comparative Effectiveness in Ulcerative Colitis
06/24/2024
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.
Dr Long reviews her presentation...
06/24/2024
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use